Adès, L.
Watts, J.
Radinoff, A.
Sangerman, M.A.
Cerrano, M.
Lopez, P.F.
Zeidner, J.
Campelo, M.D.
Graux, C.
Liesveld, J.
Selleslag, D.
Tzvetkov, N.
Fram, R.J.
Zhao, D.
Bell, J.
Friedlander, S.
Faller, D.V.
Sekeres, M.A.
This article is maintained by: Elsevier
Article Title: PHASE 2 STUDY OF PEVONEDISTAT + AZACITIDINE VERSUS AZACITIDINE IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES/CHRONIC MYELOMONOCYTIC LEUKEMIA OR LOW-BLAST ACUTE MYELOGENOUS LEUKEMIA (NCT02610777)
Journal Title: Hematology, Transfusion and Cell Therapy
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2020.10.475
Content Type: simple-article
Copyright: Copyright © 2020 Published by Elsevier Editora Ltda.